Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen

Dendritic cells (DC) vaccination is a potent therapeutic approach for inducing tumor-directed immunity, but challenges remain. One of the particular interest is the induction of an immune response targeting multiple (unknown) tumor-associated antigens (TAA), which requires a polyvalent source of TAA...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruben, Jurjen M., Bontkes, Hetty J., Westers, Theresia M., Hooijberg, Erik, Ossenkoppele, Gert J., de Gruijl, Tanja D., van de Loosdrecht, Arjan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612333/
https://www.ncbi.nlm.nih.gov/pubmed/26216454
http://dx.doi.org/10.1007/s00262-015-1741-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612333/
https://www.ncbi.nlm.nih.gov/pubmed/26216454
http://dx.doi.org/10.1007/s00262-015-1741-1

Ejemplares similares